MedTrace Logo

Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures

NCT00736684 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2011-02-11

No results posted yet for this study

Summary

The purpose of this study is to compare rates of any fracture fixation complication and revision rates after intramedullary fixation of unstable trochanteric fractures between the Proximal Femoral Nail Antirotation™ (PFNA)(Investigational Group) and Gamma Nail 3™ (Gamma3) (Control Group).

Conditions

  • Unstable Trochanteric Fractures

Interventions

DEVICE

Proximal Femoral Nail AntirotationTM (PFNA)

intramedullary nailing

DEVICE

Gamma Nail 3TM (Gamma3)

intramedullary nailing

Sponsors & Collaborators

  • Synthes Inc.

    collaborator INDUSTRY

  • AO Clinical Investigation and Publishing Documentation

    lead OTHER

Principal Investigators

  • Beate P. Hanson, MD · AO Clinical Investigation and Documentation, Davos, Switzerland

  • Javier Vaquero Martin, MD · Hospital Gregorio Marañon, Madrid, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-09-30
Completion
2010-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00736684 on ClinicalTrials.gov